Matches in Wikidata for { <http://www.wikidata.org/entity/Q95381213> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q95381213 description "article scientifique publié en 2014" @default.
- Q95381213 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95381213 description "wetenschappelijk artikel" @default.
- Q95381213 description "наукова стаття, опублікована в лютому 2014" @default.
- Q95381213 name "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 name "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 type Item @default.
- Q95381213 label "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 label "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 prefLabel "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 prefLabel "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 P1433 Q95381213-8FFA75F8-0EB1-4194-AFCC-A5C8ED1A8006 @default.
- Q95381213 P1476 Q95381213-80D1082B-0EE8-4DC0-B661-C8EEC9994070 @default.
- Q95381213 P304 Q95381213-ADD3D7DC-9F08-4F75-883D-5CE9F9C7343F @default.
- Q95381213 P31 Q95381213-997F156F-C279-4656-87EC-6A9A1C439E82 @default.
- Q95381213 P433 Q95381213-8A3EBC73-DA34-41B4-A7E2-B2D84812C252 @default.
- Q95381213 P478 Q95381213-D2849DF9-5B55-43D4-81E7-F2EEF26E88CE @default.
- Q95381213 P577 Q95381213-40A9CA39-3E61-434F-915A-CD5DFE52EAB7 @default.
- Q95381213 P698 Q95381213-1DFF7F31-5F43-4613-BAD4-465B027AF5A1 @default.
- Q95381213 P921 Q95381213-31675762-21A1-47F8-876C-50618EEA3151 @default.
- Q95381213 P698 24852790 @default.
- Q95381213 P1433 Q26867024 @default.
- Q95381213 P1476 "The combination of hypomethylating agents and histone deacetylase inhibitors (HDACi) are synergistically cytotoxic and reverse the malignant phenotype in preclinical models of T-cell lymphoma" @default.
- Q95381213 P304 "9-11" @default.
- Q95381213 P31 Q13442814 @default.
- Q95381213 P433 "2 Suppl 5" @default.
- Q95381213 P478 "12" @default.
- Q95381213 P577 "2014-02-01T00:00:00Z" @default.
- Q95381213 P698 "24852790" @default.
- Q95381213 P921 Q104053 @default.